Vitura Health Limited · ASX:VIT
Vitura Health — H1 FY2024 Earnings Presentation
23 slides from Vitura Health's earnings presentation, Feb 26, 2024
Slide 1: ASX Announcement: Investor Webinar
ASX ANNOUNCEMENT INVESTOR WEBINAR 26 FEBRUARY 2024 Melbourne, Australia – Vitura Health Limited (ASX: VIT) (Vitura and Company) is pleased to provide details of an investor webinar that will be held at the time and date set out below at which the Company’s 2024 half-year financial results will be pr
Slide 2: About Vitura Health Limited
About Vitura Health Limited (ASX:VIT) www.vitura.com.au Vitura Health Limited is diversified digital health business listed on the ASX (ASX:VIT) and, via its wholly owned subsidiaries, operates the following businesses: ● www.burleighheadscannabis.com Burleigh Heads Cannabis operates the market lead
Slide 3: Cannadoc Health Pty Ltd
● www.cannadoc.com.au The Company owns 75.5% of Cannadoc Health Pty Ltd, a medicinal cannabis clinic business that undertakes nationwide telehealth consultations with patients seeking access to medicinal cannabis. Authorised by Rodney Cocks, Chief Executive Officer and Executive Director Contact Vit
Slide 4: Business Update and H1 FY2024 Results Investor Presentation
BUSINESS UPDATE AND H1 FY2024 RESULTS INVESTOR PRESENTATION 26 FEBRUARY 2024
Slide 5: Innovating the Delivery of Healthcare: H1 FY2024 Financial Results
INNOVATING THE DELIVERY OF HEALTHCARE H1 FY2024 FINANCIAL RESULTS Vitura Health Limited Business Update and H1 FY2024 Results Investor Presentation 26 February 2024 2
Slide 6: H1 FY2024 Financial Results Overview
H1 FY2024 Financial Results Overview A more challenging trading environment was experienced in H1 FY2024 in Vitura’s primary market Competition, Pricing, Margins o Increased competition was experienced in the medicinal cannabis market in Australia in H1 FY2024 Key Financial Metrics H1 FY2024 o Proli
Slide 7: Falling prices and rebates paid have impacted sales
Falling prices and rebates paid have impacted sales Unit sales increased, however with a fall in average sales price and the need to pay rebates, there was a decrease in sales through Canview which represents a change in market dynamics Units sold through Canview Sales generated through Canview ($m)
Slide 8: Significant growth in prescriber, pharmacy accounts
Significant growth in prescriber, pharmacy accounts We are experiencing solid growth in both the number of prescriber and pharmacy accounts, driven by our nationwide data driven engagement, onboarding, education and customer success strategy Cumulative prescriber accounts Cumulative pharmacy account
Slide 9: Patient registrations and SKUs see large growth
Patient registrations and SKUs see large growth In line with increased prescribers, registered patients have also increased to nearly 11,000. The number of SKUs in the ecosystem from leading domestic and international suppliers have also increased Cumulative patients registered on Canview Number of
Slide 10: Key insights from H1 FY2024 Financial Results
Key insights from H1 FY2024 Financial Results H1 FY2024 was focused on building the foundation of prescribers and patients for the Vitura ecosystem, albeit we experienced changes in market dynamics and cost pressures o Vision26 was implemented at the start of FY2024 as a 3-year road map for growth a
Slide 11: Outlook and proactive response to market challenges
Outlook and proactive response to market challenges Recognising the market challenges, we are well positioned to implement strategic initiatives from H2 FY2024 and beyond whilst growing our patient, prescriber and pharmacy base Nationwide Increasing patients Increasing prescribers Widening the produ
Slide 12: Growth in H2 FY2024 and Beyond
GROWTH IN H2 FY2024 AND BEYOND Where to from here? The future of Vitura is focussed on innovating the delivery of healthcare, by building out a centralised healthcare experience that connects and enhances each stage of the patient experience and journey throughout their lifetime. Vitura Health Limit
Slide 13: Diversification into digital health
While we will continue to be a leader in the medicinal cannabis space, we are focussed on diversification into new markets in the digital health space and targeted at enhancing the healthcare experience of patients. We have a solid foundation and proven success with the Canview platform, and recentl
Slide 14: How the Vitura ecosystem works to create value
How the Vitura ecosystem works to create value At its core the Vitura ecosystem enables interactions between users to create value for all platform participants CREATION OF VALUE Examples of potential value creation ENABLE GENERATE REACH INTERACTIONS NETWORK EFFECTS CRITICAL MASS A platform business
Slide 15: Broadening our service vertical markets
Broadening our service vertical markets By broadening our offering through service vertical markets, we are well placed to enhance the end-to-end healthcare experience Smoking Cessation Mental Health o In 2023 there were 11.8%, o Significant demand for consults for GP mental or 3.14m smokers, in Aus
Slide 16: The Vitura Ecosystem
The Vitura Ecosystem The Vitura ecosystem enables its participants to interact with each other to both create value for users flowing through, and then capture value at different points to provide sustainable business growth. As more users flow through the ecosystem, the more valuable it becomes for
Slide 17: Linking patients with consults and products
Linking patients with consults and products The Canview and Doctors on Demand platforms are integral pieces of the overall Vitura ecosystem coming together to enhance the healthcare experience for current and prospective patients Front end patient access Internal and external prescribers, pharmacies
Slide 18: We are a digital health company enhancing the healthcare experience
WE ARE A DIGITAL HEALTH COMPANY ENHANCING THE HEALTHCARE EXPERIENCE, NOT JUST A MEDICINAL CANNABIS COMPANY While we grew to become Australia’s most successful medicinal cannabis company, we are now targeting a vision to become Australia’s most successful digital health company which enhances the hea
Slide 19: Your questions please
Your questions please Thank you Vitura Health Limited Business Update and H1 FY2024 Results Investor Presentation 26 February 2024 16
Slide 20: The Team – Board and Executive
The Team – Board and Executive Strategy and execution focused We have assembled an experienced, commercially-focused team to execute on the Vision26 strategy and create sustainable shareholder value over the long term. Experienced Board combining deep business development, sales, distribution, brand
Slide 21: Disclaimer
DISCLAIMER 18
Slide 22: Disclaimer applying to this Presentation
Disclaimer applying to this Presentation The following disclaimer applies to this presentation (Presentation) You are therefore advised to read this disclaimer carefully before reading or making any other use of this Presentation or any information contained in this Presentation. This Presentation h
Slide 23: Vitura Health Limited
VITURA HEALTH LIMITED ASX : VIT vitura.com.au info@vitura.com.au 1300 799 491